Skip to main
KMB

Kimberly-Clark (KMB) Stock Forecast & Price Target

Kimberly-Clark (KMB) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 8%
Buy 17%
Hold 67%
Sell 0%
Strong Sell 8%

Bulls say

Kimberly-Clark is positioned as a leading manufacturer in the tissue and hygiene industry, deriving over half of its sales from personal care products and a significant portion from consumer tissue, with strong brand presence through products like Huggies, Kleenex, and Depend. The company is focused on enhancing innovation and anticipates a robust pipeline in 2026, which supports its ability to introduce improved products and technologies, thereby potentially increasing market share. Moreover, with sales distribution primarily in North America, Europe, and expanding efforts in Asia and Latin America, alongside plans to integrate Kenvue's consumer health portfolio, Kimberly-Clark is strategically set to leverage its diversified markets and product offerings for future growth.

Bears say

Kimberly-Clark is facing a concerning trend with an estimated -4.0% organic sales decline in North America for the third quarter of 2025, markedly lower than the previous expectation of +4.5%. Furthermore, the company has reported a -2.7% decline in measured retail sales in the U.S. for the third quarter of 2025 year-to-date. In response to these challenges, the firm has revised its earnings per share (EPS) estimates downward, reducing the forecasts for fiscal 2025 from $7.60 to $7.41 and for 2026 from $8.00 to $7.85.

Kimberly-Clark (KMB) has been analyzed by 12 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 17% recommend Buy, 67% suggest Holding, 0% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Kimberly-Clark (KMB) Forecast

Analysts have given Kimberly-Clark (KMB) a Hold based on their latest research and market trends.

According to 12 analysts, Kimberly-Clark (KMB) has a Hold consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $121, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $121, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Kimberly-Clark (KMB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.